Quarterly report pursuant to Section 13 or 15(d)

Warrants

v3.19.1
Warrants
3 Months Ended
Mar. 31, 2019
Other Liabilities Disclosure [Abstract]  
WARRANTS

Note 10 – Warrants

 

The following table summarizes information about outstanding and exercisable warrants at March 31, 2019:

 

        Number of     Shares     Shares              
        Shares     Underlying     Underlying              
        Underlying     Warrants     Warrants              
        Warrants     Exchanged,     Outstanding           Expiration  
        Originally     Exercised     and     Exercise     Term  
Description   Grant Date   Granted     or Expired     Exercisable     Price     in years  
Series B(1)   January 27, 2014     157,846       (157,846     -     $ -       -  
Series C(2)   November 19, 2014     145,399       (142,957 )     2,442     $ 12.00       0.75  
Repricing Series C(2)   November 19, 2014             142,957       142,957     $ 9.00       0.75  
Repricing Series E(2)   November 19, 2014     -       142,957       142,957     $ 9.00       0.75  
Rens(3)   March 3, 2016     375,000       -       375,000     $ 7.00       0.75  
Total         678,245       (14,889     663,356                  

 

(1) Issued in connection with the January 27, 2014 private placement transaction and which expired in January 2019.
(2) Issued in connection with the November 19, 2014 registered-direct public offering, and subsequently revised pursuant to Warrant Exercise Agreements entered into on May 18, 2015.
(3) Shares issued pursuant to the closing of the first tranche of the financing with RENS Technology Inc.